Shanghai Junshi Biosciences Co Ltdor Junshi Biosciencesis A Biopharmaceutical Company Based In Shanghaichinafounded In December 2012The Company Focuses On The Discoverydevelopmentand Commercialization Of Innovative Therapiesparticularly First In Class And Best In Class Drugsjunshi Biosciences Aims To Address Unmet Medical Needs By Developing Treatments For Various Diseasesincluding Cancerautoimmune Disordersmetabolic Conditionsneurological Issuesand Infectious Diseases The Company Has A Diverse Portfolio That Includes Monoclonal Antibodies Like Toripalimab And Adalimumabas Well As Small Molecule Drugs And Antibody Drug Conjugatesjunshi Biosciences Also Maintains A Robust Pipeline Of Productsreflecting Its Commitment To Research And Developmenttargeting Markets Primarily In China And The United Statesthe Company Is Dedicated To Providing Trustworthy And Affordable Treatments To A Broad Patient Basewith A Strong Emphasis On Innovation And A Comprehensive Industry Chainjunshi Biosciences Is Positioned For Continued Growth In The Biopharmaceutical Sector
